BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.
about
Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer.A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.Biliary tract cancer stem cells - translational options and challenges.
P2860
BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
BRCA/Fanconi anemia pathway im ...... abine in biliary tract cancer.
@ast
BRCA/Fanconi anemia pathway im ...... abine in biliary tract cancer.
@en
type
label
BRCA/Fanconi anemia pathway im ...... abine in biliary tract cancer.
@ast
BRCA/Fanconi anemia pathway im ...... abine in biliary tract cancer.
@en
prefLabel
BRCA/Fanconi anemia pathway im ...... abine in biliary tract cancer.
@ast
BRCA/Fanconi anemia pathway im ...... abine in biliary tract cancer.
@en
P2093
P2860
P356
P1433
P1476
BRCA/Fanconi anemia pathway im ...... abine in biliary tract cancer.
@en
P2093
Akira Tomokuni
Hidetoshi Eguchi
Hiroaki Nagano
Hiroshi Wada
Koichi Kawamoto
Naoki Hama
Shigeru Marubashi
Shinsuke Nakashima
Shogo Kobayashi
Tadafumi Asaoka
P2860
P304
P356
10.1111/CAS.12652
P577
2015-04-22T00:00:00Z